News Formal

AstraZeneca approaches Gilead about potential merger

  • 📰 latimes
  • ⏱ Reading Time:
  • 23 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 82%

South Africa News News

South Africa South Africa Latest News,South Africa South Africa Headlines

AstraZeneca Plc has made a preliminary approach to rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter, in what would be the biggest healthcare deal on record.

AstraZeneca has made a preliminary approach to rival drugmaker Gilead Sciences Inc. about a potential merger, according to people familiar with the matter, in what would be the biggest healthcare deal on record.

AstraZeneca, valued at $140 billion, is the U.K.’s biggest drugmaker by market capitalization and has developed treatments for conditions including cancer and cardiovascular disease. Gilead, worth $96 billion at Friday’s close, is the creator of a drug that has received U.S. approval for use with coronavirus patients.

Shares of AstraZeneca have risen about 41% over the last 12 months. Shares of Gilead gained about 19% over the period.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

AstraZeneca has been claiming for years that they could turn things around without a major purchase or merger..Wall St was skeptical - AstraZeneca approaches Gilead about potential merger

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 11. in ZA

South Africa South Africa Latest News, South Africa South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

AstraZeneca approached Gilead about potential merger - Bloomberg NewsAstraZeneca Plc has approached rival drugmaker Gilead Sciences Inc about a potential merger, Bloomberg News reported on Sunday, citing people familiar with the matter. Hope combined R&D could expedite coronavirus vaccine. That's an interesting news, but it may be too early Of course they did. THE ONLY ONES GETTING RICHER WHILE THE POOR BECOMES MORE IMPOVERISHED....
Source: Reuters - 🏆 2. / 97 Read more »

AstraZeneca approached Gilead about potential merger - Bloomberg NewsAstraZeneca Plc has approached rival drugmaker Gilead Sciences Inc about a potential merger, Bloomberg News reported on Sunday, citing people familiar with the matter. Hope combined R&D could expedite coronavirus vaccine. That's an interesting news, but it may be too early Of course they did. THE ONLY ONES GETTING RICHER WHILE THE POOR BECOMES MORE IMPOVERISHED....
Source: Reuters - 🏆 2. / 97 Read more »